The affected devices were distributed between Oct. 9 and Oct. 29, 2009. They include the following lot numbers:
- Aisys (model no. 1011-9000-000) — ANAN00814, ANAN00815, ANAN00825, ANAN00830, ANAN00831, ANAN00831, ANAN00832, ANAN00833, ANAN00834, ANAN00835, ANAN00836, ANAN00837, ANAN00838, ANAN00839, ANAN00873
- Avance (model no. 1009-9002-000) — ANBN01180, ANBN01187, ANBN01200, ANBN01201, ANBN01211, ANBN01212, ANBN01213, ANBN01220, ANBN01223, ANBN01224, ANBN01250, ANBN01266, ANBN01284, ANBN01285, ANBN01286, ANBN01287, ANBN01288, ANBN01289
The Aisys and Avance systems are prescription devices used in healthcare settings under the supervision of a physician and are used to provide general inhalation anesthesia and ventilation support to a wide range of patients, according to the release.
Customers were notified by the FDA on March 12, 2010. Adverse events associated with the device may be reported to the FDA’s MedWatch program.
Read the FDA’s recall of GE’s Aisys and Avance Anesthesia systems.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
